MHRA grants approval for second Pfizer/Biontech bivalent Covid-19 booster vaccine

By | November 9, 2022
Approval has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a Pfizer/BioNTech ‘bivalent’ Covid vaccine that targets both the Original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.